Biotech Stock Flashing Bull Signal

Sarepta Therapeutics (SRPT) staged quite a slide after its June 21 three-year high of $173.25, closing six of the last seven weeks lower. The shares are in positive territory so far this week, however, as the stock extends a bounce off the $125 level. Plus, a historically bullish signal could provide support on the charts, adding to the stock's 36% year-to-date lead. Sarepta Therapeutics stock's pullback has it within one standard deviation of its 126-day moving average. According to Schaeffer's Senior Quan ...